openPR Logo
Press release

Hormone Replacement Therapy Market COVID-19 Impact and Global Analysis by Product Type, Indication, End User, and Geography

12-27-2021 09:43 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Future Market Insights

Hormone Replacement Therapy Market COVID-19 Impact and Global

Hormone Replacement Therapy is any form of hormone therapy where in the patient, in course of medical treatment, receives hormones, either to supplement a lack of naturally occurring hormones, or to substitute other hormones for naturally occurring hormones.

Menopause, is the time in most women's lives when menstrual periods stop permanently, and the woman is no longer able to have children. Menopause typically occurs between 45 and 55 years of age. Medical professionals defined by a decrease in hormone production by the ovaries. In those who have had surgery to remove the uterus but still have ovaries, menopause generally occurs at the time of the surgery or when hormone levels fall. Following the removal of the uterus, symptoms typically occur earlier at the average of 45 years of age.

Gain complete access to the report @ https://www.futuremarketinsights.com/reports/hormone-replacement-therapy-market

Estrogen and progesterone are female hormones that play important roles in a woman’s body. Falling levels cause a range of physical and emotional symptoms, including hot flushes, mood swings and vaginal dryness. The aim of hormone replacement therapy is to restore female hormone levels, allowing the body to function normally again.

Hormone Replacement Therapy Market: Drivers and Restraints

The prime drivers of hormone replacement therapy are increased demand from regenerative medicines such as anti-aging and reproductive-cycle boosting therapy such as menopausal hormone replacement. Rising demand in other therapeutic areas such as Growth Hormone Therapy and Thyroid Hormone Therapy due to comparatively safe profile, efficiency, and cost effectiveness of these drugs is expected to positively impact market growth. Moreover, new formulations such as transdermal drugs, gels and creams that offer benefits such as ease of drug administration and impact at location are expected to increase the growth of hormone replacement therapy market during the forecast period. Advantages associated with the hormone replacement therapy such as reduction in risk incidence of osteoporosis, cardiovascular disease, and reduction of vasomotor symptoms are also expected to boost the growth of hormone replacement therapy market in the coming years.

Hormone Replacement Therapy has side effects such as fluid retention, headache, indigestion, and depression. These are anticipated to hamper the popularity of the therapeutic area. Furthermore, UK-based NICE notes that hormone replacement therapy could be associated with breast cancer risk if the drugs oestrogen and progesterone are taken in combination. Prolonged consumption of HRT drugs could also lead to increased risk of blood clots. Studies have estimated that for every 1,000 women taking HRT tablets for 7.5 years, less than two will develop a blood clot. These restraints seem quite negligible when compared with the benefits of HRT.

To remain ‘ahead’ of your competitors, request for a sample - https://www.futuremarketinsights.com/reports/sample/rep-gb-3871

Hormone Replacement Therapy Market: Overview

Increasing use of HRT in menopause conditions due to safety, efficacy and cost effectiveness of the drugs are expected to boost the growth of the Global Hormone Replacement Therapy market. North America is contributing more income to the Global Hormone Replacement Therapy and Asia region is showing fastest growth rate because of having more population base in this region.

Hormone Replacement Therapy Market: Region wise Outlook

Depending on geographic regions, Global Hormone Replacement Therapy market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific, Japan, and Middle East & Africa. North America is having more market for Hormone Replacement Therapy, In North America, U.S. represents the largest market because of increasing use of Hormone Replacement Therapy among patients aged 35 years and over. The availability of compounded drugs i.e. drugs in varied strengths, dosage forms, etc – is a major factor, which tends to boost the revenue growth of this extremely popular treatment market. Early onset of aging coupled with rising disposable income levels are other important factors fuelling market revenue growth.

Asia region is expected to have more growth rate in upcoming years because of increasing awareness about Hormone Replacement Therapy in this region. In Asia region India, China, Japan are expected to have more growth rate for Hormone Replacement Therapy.

Hormone Replacement TherapyMarket: Key Players

Some of the key market players in Global Hormone Replacement Therapy market are Bayer AG, Pfizer, Merck & co., BioSante Pharmaceuticals and Amgen, QuatRx Pharmaceuticals, Noven Pharmaceuticals.

The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.

Get a Customized Scope to Match Your Need Ask an Expert- https://www.futuremarketinsights.com/ask-question/rep-gb-3871

The report covers exhaustive analysis on:

Market Segments
Market Dynamics
Market Size
Supply & Demand
Pipeline Assessment
Current Trends/Issues/Challenges
Competition & Companies involved
Technology
Value Chain
Regional analysis includes

North America (U.S., Canada)
Latin America (Mexico, Brazil and Rest of Latin America)
Western Europe (Germany, Italy, France, U.K, Spain, Nordic countries, Belgium, Netherlands, Luxembourg and Rest of Western Europe)
Eastern Europe (Poland, Russia and Rest of Eastern Europe)
Asia Pacific without Japan (China, India, ASEAN, Australia & New Zealand, Rest of Asia Pacific without Japan)
Japan
Middle East and Africa (GCC, S. Africa, and Rest of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Hormone Replacement Therapy Market: Segmentation
Based on Therapy Type,

Estrogen Replacement Therapy
Growth Hormone Replacement
Dopamine Agonist
Somatostatin Analogues
Thyroid Hormone Replacement
Tablets
Capsules
Injections
Based on Application

Cancer
Menopause
Hypopituitarism
Hypothyroidism
Others
Based on Distribution Channel

Hospital Pharmacies
Retail Pharmacies and Drugstores
Compounding Pharmacies
E-commerce
Others

For critical insights, request for PDF Brochure: https://www.futuremarketinsights.com/reports/brochure/rep-gb-3871

Report Highlights:

Detailed overview of parent market
Changing market dynamics in the industry
In-depth market segmentation
Historical, current and projected market size in terms of volume and value
Recent industry trends and developments
Competitive landscape
Strategies of key players and products offered
Potential and niche segments, geographical regions exhibiting promising growth
A neutral perspective on market performance
Must-have information for market players to sustain and enhance their market footprint

Contact:
Future Market Insights,
1602-6 Jumeirah Bay X2 Tower,
Plot No: JLT-PH2-X2A,
Jumeirah Lakes Towers, Dubai,
United Arab Emirates
For Sales Enquiries: sales@futuremarketinsights.com
For Media Enquiries: press@futuremarketinsights.com
Website: https://www.futuremarketinsights.com/

About Future Market Insights (FMI)
Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and industry analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert-led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Hormone Replacement Therapy Market COVID-19 Impact and Global Analysis by Product Type, Indication, End User, and Geography here

News-ID: 2511219 • Views: 131

More Releases from Future Market Insights

Critical Care Information Systems Market Key Players- Affiliated Computer Servic …
Critical care information systems are used to help manage the large amount of data generated in an intensive care unit every day. Obtaining, synchronizing, assimilating, and evaluating patient data is very difficult because of incompatibilities among monitoring equipment, the absence of standard data formatting and proprietary limitations from industry. The intensive care units are a specialized section of a hospital containing the equipment, medical and nursing staff, monitoring and life
Paper Cores Demand Catalyzes amid High Emphasis on Circular Economy: FMI Study
The global packaging industry has made remarkable progress in recent years, with numerous innovations and technological advances prioritized. Particular emphasis is placed on ensuring sustainability and the spread of the circular economy. Reliable benefits have been obtained in reducing the generation of municipal solid waste. Future Market Insights is a recently published research report that incorporates historical analysis from 2015 to 2019 and future assessments from 2020 to 2030 to
Endometrial Cancer Treatment Market Key Players- R-Pharm-US LLC., Bristol-Myers …
Endometrial cancer or uterine cancer is one of the most common gynecological cancers and 2.8% of women are diagnosed with the endometrial cancer at some point in their lives. According to National Cancer Institute statistics, in 2015 endometrial cancer contributed to 1.8% of all cancers and 3.6% of all new cancer cases were diagnosed as endometrial cancer. Early detection of endometrial cancer helps in the selection of proper treatment options.
Elastic Laminate Market Study: An Emerging Hint of Opportunity by 2028
Elastic laminates will exceed US $ 5 billion in 2019, an increase of 5.1% compared to 2018. A new FMI survey on elastic laminates around the world predicts strong adoption of elastic laminates by manufacturers of personal hygiene products, which currently hold an almost 85% share. .. Baby diapers are the most popular for applying elastic laminates, but the share of women's hygiene products is also growing rapidly. In addition,

All 5 Releases


More Releases for Hormone

Luteinizing Hormone-releasing Hormone Analogs Market Size, Analysis, Research, S …
" Los Angeles, United States – – QY Research offers an overarching research and analysis-based study on the global Luteinizing Hormone-releasing Hormone Analogs market, covering growth prospects, market development potential, profitability, supply and demand, and other important subjects. The report presented here comes out as a highly reliable source of information and data on the global Luteinizing Hormone-releasing Hormone Analogs market. The researchers and analysts who have prepared the report used
Peptide Hormone Market- Key Development by 2026
Worldwide Peptide Hormone Market report of 2019 provides a detailed market overview as well as industry analysis for / of companies, manufacturers and distributors covering data on gross margin, cost structure, consumption value, sale price and more. The recent research report on the global Peptide Hormone market presents the latest industry data and future trends, allowing you to recognize the products and end users driving Revenue growth and profitability of the
Peptide Hormone Global Industry Report - History, Present and Future 2025
The global market size of Peptide Hormone is $XX million in 2017 with XX CAGR from 2013 to 2017, and it is expected to reach $XX million by the end of 2023 with a CAGR of XX% from 2018 to 2023. There are 3 key segments covered in this report: geography segment, end use/application segment and competitor segment. For geography segment, regional supply, application-wise and type-wise demand, major players, price is presented
Hormone Replacement Therapy Market Segments And Key Trends 2018-2028
Top Five Companies Account for 35% Share of the Overall Hormone Replacement Therapy Market The hormone replacement therapy market is a fragmented landscape with presence of few tier one companies and upcoming players. Top five companies involved in the hormone replacement therapy formulations account for a significant share of the overall hormone replacement therapy market. Top 5 players – Novo Nordisk, Pfizer Inc., Janssen NV (a Johnson & Johnson company), Novartis AG and
Follicle Stimulating Hormone Market
"This report studies the follicle stimulating hormone market. Follicle stimulating hormone (FSH) is a hormone made by the pituitary gland that affects the gonads (female ovaries and males testes). In females, it stimulates growth of the ovarian follicles. In this report, it refers to follicle stimulating hormone drugs for human use. 1 dose is equal to 75 IU." Scope of the Report: This report focuses on the Follicle Stimulating Hormone in United States market,
Industrial Report: Global Hormone Agonists Market
Marketresearchreports.biz has added a new research report on the "Hormone Agonists-Pipeline Insights, 2017" to its collection. DelveInsights, Hormone Agonists-Pipeline Insights, 2017, report provides in depth insights on the pipeline drugs and their development activities around the Hormone Agonists. The DelveInsights Report covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other